196 related articles for article (PubMed ID: 10518231)
21. A review of "once-a-month" combined injectable contraceptives.
Newton JR; D'arcangues C; Hall PE
J Obstet Gynaecol (Lahore); 1994; 4 Suppl 1():S1-34. PubMed ID: 12290848
[TBL] [Abstract][Full Text] [Related]
22. Existing once-a-month combined injectable contraceptives.
Toppozada MK
Contraception; 1994 Apr; 49(4):293-301. PubMed ID: 8013216
[TBL] [Abstract][Full Text] [Related]
23. Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.
Hall P; Bahamondes L; Diaz J; Petta C
Contraception; 1997 Dec; 56(6):353-9. PubMed ID: 9494768
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
[TBL] [Abstract][Full Text] [Related]
25. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
Seibert B; Günzel P
Contraception; 1994 Apr; 49(4):303-33. PubMed ID: 8013217
[TBL] [Abstract][Full Text] [Related]
26. Acceptability of injectable contraceptives in Assiut, Egypt.
Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Contraception; 1998 Feb; 57(2):71-81. PubMed ID: 9589832
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction.
Contraception; 1997 Oct; 56(4):193-207. PubMed ID: 9408700
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem in Chinese women.
Zhou XF; Shao QX; Han XJ; Weng LJ; Sang GW
Contraception; 1998 Jun; 57(6):405-11. PubMed ID: 9693401
[TBL] [Abstract][Full Text] [Related]
30. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
Cochrane Database Syst Rev; 2013; 3():CD004568. PubMed ID: 23641480
[TBL] [Abstract][Full Text] [Related]
31. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
Ruminjo JK; Sekadde-Kigondu CB; Karanja JG; Rivera R; Nasution M; Nutley T
Contraception; 2005 Aug; 72(2):138-45. PubMed ID: 16022854
[TBL] [Abstract][Full Text] [Related]
32. Medical contraindications and issues for consideration in the use of once-a-month injectable contraceptives.
Dorflinger LJ
Contraception; 1994 May; 49(5):455-68. PubMed ID: 8045132
[TBL] [Abstract][Full Text] [Related]
33. Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
Garza-Flores J; Alba VM; Cravioto MC; Hernandez L; Perez-Palacios G; Alvarado G; Rivera R; Recio R; Bassol S
Contraception; 1989 May; 39(5):519-29. PubMed ID: 2524362
[TBL] [Abstract][Full Text] [Related]
34. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
Datey S; Gaur LN; Saxena BN
Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
[TBL] [Abstract][Full Text] [Related]
35. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
36. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
37. Uniject as a delivery system for the once-a-month injectable contraceptive Cyclofem in Brazil.
Bahamondes L; Marchi NM; de Lourdes Cristofoletti M; Nakagava HM; Pellini E; Araujo F; Rubin J
Contraception; 1996 Feb; 53(2):115-9. PubMed ID: 8838489
[TBL] [Abstract][Full Text] [Related]
38. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Schulz KF; d'Arcangues C; Lopez LM
Cochrane Database Syst Rev; 2005 Jul; (3):CD004568. PubMed ID: 16034938
[TBL] [Abstract][Full Text] [Related]
39. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD004568. PubMed ID: 18843662
[TBL] [Abstract][Full Text] [Related]
40. Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group.
Kaunitz AM; Garceau RJ; Cromie MA
Contraception; 1999 Oct; 60(4):179-87. PubMed ID: 10640164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
